Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06652503 · ClinicalTrials.gov registry record · NA

The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program

A NA study of Depression and Anxiety, sponsored by Nova Southeastern University.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT06652503 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 160 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06652503, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Nova Southeastern University.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to provide a free 6-week, online psychological coaching program to NSU undergraduate students to help with anxiety, depression, and stress, while improving quality of life and healthy coping skills.

Interventions

  • BEHAVIORAL online mental health coaching

Study Locations (1)

Florida

  • Nova Southeastern University - Fort Lauderdale

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-01-13
Est. Completion 2026-09
Phase NA

Sponsor

Nova Southeastern University

71 total trials

What the Registry Record Tells You About NCT06652503

The ClinicalTrials.gov registry entry for NCT06652503 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (80% lower). The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which online mental health coaching is the first listed.

NCT06652503 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06652503 about?

NCT06652503 is a clinical study titled "The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program". The purpose of this research study is to provide a free 6-week, online psychological coaching program to NSU undergraduate students to help with anxiety, depression, and stress, while improving quality of life and healthy coping skills.

What is the current status of trial NCT06652503?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-01-13. Estimated completion is 2026-09.

What conditions does trial NCT06652503 study?

This clinical trial studies the following conditions: Depression, Anxiety, Stress, Quality of Life, Wellbeing.

What interventions are being tested in trial NCT06652503?

The interventions under investigation include: online mental health coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT06652503?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06652503 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.